Tom’s of Maine teams up with nonprofit organization
KENNEBUNK, Maine Tom’s of Maine, a manufacturer of natural personal care products, has teamed up with Charity: water, a U.S.-based nonprofit organization dedicated to bringing clean and safe drinking water to people in developing nations.
Through Dec. 31, Tom’s of Maine will match each $5 donation made by texting WELL to 20222, up to $10,000, to fund water projects in areas most in need. One hundred percent of the public’s donations will go directly to freshwater projects. Tom’s of Maine is also supporting charity: water’s 100% model by providing additional funds to underwrite the costs of this campaign.
“Our goal for this initiative is to build four wells, which cost only $5,000 each, but can bring lasting, positive change to so many,” stated Kate Bussell at Tom’s of Maine. “Charity: water shares our deep connection to clean water, and we commend them on the more than 1,400 water projects they’ve already completed in just three short years.”
J&J reports Q3 results
NEW BRUNSWICK, N.J. Stock prices for drug maker Johnson & Johnson fell in morning trading Tuesday following the company’s release of a lackluster financial report.
J&J’s stock fell by $1.51, to $61.02 late in the morning after the company posted a 5.3% decline in third-quarter 2009 sales, to $15.1 billion, compared with third quarter 2008. Domestic sales decreased by 8.1%, while international sales decreased by 2.5%, though the weakness of the dollar provided a buffer against a steep decline.
Pharmaceutical sales had the steepest decline, falling by 14.1% to $5.3 billion, including a 19.2% decrease in domestic sales and a 7.1% decrease in international sales. Consumer products had sales of $4 billion, a 2.7% decline over the year before.
At the same time, individual products showed strong growth. The autoimmune drug Remicade (infliximab) sold well, as did the HIV drug Prezista (darunavir) and the multiple myeloma drug Velcade (bortezomib). J&J also got several new drug approvals, such as the Food and Drug Administration’s approval of the autoimmune drug Stelara (ustekinumab) and the European Commission’s approval of the arthritis drug Simponi (golimumab).
Among consumer products, the Aveeno line of skin care products and the artificial sweetener Splenda showed strong growth, as well as the mouthwash Listerine and the Le Petit Marseillais line of beauty care products.
“We continue to successfully manage our broad base of businesses and deliver solid earnings despite the impact of patent expirations and challenges posed by the current economic environment,” chairman and CEO William Weldon said in a statement. “We completed multiple acquisitions and strategic collaborations and received several new product approvals in the quarter that will benefit patients worldwide and drive future growth.”
Walmart.com launches health, beauty products online for home delivery
BRISBANE, Calif. Walmart.com is looking to go head-to-head with online retailers of health-and-beauty aids by offering home delivery of such products.
By visiting www.walmart.com/health, shoppers can choose from thousands of such national brands as Neutrogena, L’Oreal, Colgate, Pantene and Gillette, and have those products shipped to their homes for 97 cents per item.
For example, Maybelline New York’s Colossal Classic Volum’ Express Washable Mascara is priced at less than $6 and Sudafed Caplets Severe Cold Multi-Symptom 24-ct is also priced at less than $6.
Free samples of select health and beauty products are also available.